Strategic Partnership HOCHDORF is pursuing international expansion through partnerships, exemplified by the 2026 collaboration with Pharmalys. This signals openness to channel and co-development opportunities that sales teams can leverage to cross-sell infant nutrition, specialized milk powders, and ingredient solutions in new markets.

Leadership Transition New CEO Sandro Tichelli appointed for 2026, aligned with a potential strategic refresh and growth initiatives. This presents an opening to engage at the executive level with a tailored value story around scalable production, innovation in milk-based and alternative protein ingredients, and geographic expansion plans.

Expansion Focus With a history of consolidating and exiting older facilities and a shift toward global industrial customers, there is momentum for selling high-value functional ingredients, dairy powders, and goat milk infant products (Bimbosan) to markets seeking diverse protein sources and infant nutrition options.

Technology Enablement HOCHDORF leverages AWS, Microsoft 365, iCIMS and other modern platforms, indicating a capability and appetite for tech-enabled partnerships, digital supply chain solutions, and scalable manufacturing services that can be co-marketed to customers seeking reliability and innovation in dairy and alternative protein ingredients.

Niche Advantage As a Swiss centre of excellence for milk processing with a focus on infant nutrition and powder drying, HOCHDORF targets premium, science-driven segments. This creates opportunities for premium collaborations, private-labeling, and joint ventures with brands seeking high-quality Swiss-made dairy and goat-m Milk products.